CClinicalTrials.gg
Sign In
CompletedNCT02027467HematoaliveUpdated May 6, 2014

Study to Assess the Effect of StemAlive® Supplement on the Levels of Stem Cells in Human Volunteers

An interventional study of StemAlive® and Placebo (For StemAlive®) in Healthy, sponsored by Vedic Lifesciences Pvt. Ltd.. Completed at 1 site in India. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-05-06.

Sponsored by Vedic Lifesciences Pvt. Ltd. · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Combination of various herbs is known to promote mobilization of hematopoietic stem cells. Hence the current study has been intended to study the effect of Stem Alive® on mobilization of stem cells. Stem Alive® include ingredients like green tea, ashwagandha, etc which are known to be used as traditional medicine. They are also tested qualitatively in academic and nutritional science research centers throughout the world and which substantially according to those studies stimulate the augmented availability of circulating hematopoietic cells. This study is projected to investigate the mobilization of stem cells on healthy human volunteers.

02

Conditions studied

  • Healthy

Keywords

  • Hematopoietic stem cells
  • Herbal
  • Dietary
  • CD cells
  • Basic research
03

In context

Lead sponsor

Vedic Lifesciences Pvt. Ltd. is the lead sponsor of 71 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy Male and Female Volunteers
  • Willing to sign Informed Consent Form

Exclusion criteria

Exclusion Criteria:

  • Anemia
  • SGOT and Serum Creatinine values twice the upper limit of normal
  • Volunteers who smoke / consume alcohol / take recreational drugs
  • Fever or Flu in the last one week of screening
  • History of Gastric or Duodenal Ulcer
  • Volunteers on vitamins, nutritional or herbal products since last one month
  • Pregnant, Breast feeding and Lactating women
  • Volunteers taking antibiotic, NSAIDS, anti-inflammatory within last 7 days
  • Allergic to ingredients of test product
  • Any co morbid or systemic condition or immunocompromised state making volunteer unfit for participation.
  • Volunteers deemed unfit for the study by the Investigator
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    StemAlive®

    Stem Alive® includes ingredients like green tea, ashwagandha. Dose: 3 capsules twice daily to be taken orally for 14 days.

    Dietary Supplement: StemAlive®

  • Placebo comparator
    Placebo

    Matching placebo capsules (for StemAlive®) containing polyethylene glycol, rice powder and magnesium stearate. Dose: 3 capsules twice daily to be taken orally for 14 days.

    Dietary Supplement: Placebo (For StemAlive®)

Interventions

  • Dietary supplementStemAlive®
  • Dietary supplementPlacebo (For StemAlive®)
06

What researchers measure

Primary outcomes

  1. CD34+

    Time frame: Day 0, Day 1, Day 2, Day 7, Day 12 and Day 14

  2. CD45+

    Time frame: Day 0, Day 1, Day 2, Day 7, Day 12 and Day 14

  3. CD133+

    Time frame: Day 0, Day 1, Day 2, Day 7, Day 12 and Day 14

07

Study locations

1 site
  • Dhanwantari Clinic
    Mumbai, Maharashtra 400072, India
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 6, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02027467
Lead sponsor
Vedic Lifesciences Pvt. Ltd.
Collaborators
Stem Vida International
Responsible party
Sponsor
First posted
Jan 6, 2014
Start date
Feb 2014
Primary completion
Apr 2014
Completion
Apr 2014
Last update
May 6, 2014

Study contacts

Sandip Patil, MD
principal investigator

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Vedic Lifesciences Pvt. Ltd.

Start the discussion